Synergistic antitumor effect of the combination of a dual cancer‑specific oncolytic adenovirus and cisplatin on lung cancer cells

作者: Jing Jin , Yilong Zhu , Fei Sun , Zhifei Chen , Shuang Chen

DOI: 10.3892/OL.2018.9470

关键词: CisplatinA549 cellApoptosisLung cancerOncolytic adenovirusIn vivoOncogeneMedicineCancer researchCancer

摘要: The effect of the combination a recombinant adenovirus (ATV) expressing specific apoptin protein and cisplatin on human lung cancer cells (A549 cells) was determined. inhibitory effects ATV cisplatin, alone, or alone migration invasion A549 were evaluated in vitro using cell proliferation, wound healing, Transwell Matrigel assays. tumor inhibition vivo assessed by observing growth survival rate nude mice with subcutaneous xenografts grown from implanted after treatment ATV, combined cisplatin. proliferation (P<0.01), (P<0.01) suppressed significantly dose- time-dependent manner. transplanted group higher than that displayed other groups, treated alone. results indicated application could reduce toxicity showed synergistic reducing increasing survival. Thus, there is potential research value treating tumors which provides foundation for future preclinical studies this antitumor treatment.

参考文章(26)
James Burke, Jorge Nieva, Mitesh J Borad, Caroline J Breitbach, Oncolytic viruses: perspectives on clinical development Current Opinion in Virology. ,vol. 13, pp. 55- 60 ,(2015) , 10.1016/J.COVIRO.2015.03.020
Subbareddy Maddika, Francisco J. Mendoza, Kristin Hauff, Christina R. Zamzow, Ted Paranjothy, Marek Los, Cancer-selective therapy of the future: apoptin and its mechanism of action. Cancer Biology & Therapy. ,vol. 5, pp. 10- 19 ,(2006) , 10.4161/CBT.5.1.2400
LEI LIU, WENBIN WU, GUANGZE ZHU, LIMING LIU, GUOFANG GUAN, XIAO LI, NINGYI JIN, BAORONG CHI, Therapeutic efficacy of an hTERT promoter-driven oncolytic adenovirus that expresses apoptin in gastric carcinoma International Journal of Molecular Medicine. ,vol. 30, pp. 747- 754 ,(2012) , 10.3892/IJMM.2012.1077
Badreldin H. Ali, Mansour S. Al Moundhri, Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: A review of some recent research Food and Chemical Toxicology. ,vol. 44, pp. 1173- 1183 ,(2006) , 10.1016/J.FCT.2006.01.013
Yanxin Qi, Huanhuan Guo, Ningning Hu, Dongyun He, Shi Zhang, Yunjie Chu, Yubin Huang, Xiao Li, LiLi Sun, Ningyi Jin, Preclinical pharmacology and toxicology study of Ad-hTERT-E1a-Apoptin, a novel dual cancer-specific oncolytic adenovirus. Toxicology and Applied Pharmacology. ,vol. 280, pp. 362- 369 ,(2014) , 10.1016/J.TAAP.2014.08.008
Viktor Brabec, Jana Kasparkova, Molecular aspects of resistance to antitumor platinum drugs. Drug Resistance Updates. ,vol. 5, pp. 147- 161 ,(2002) , 10.1016/S1368-7646(02)00047-X
Sirik R Leliveld, Remus T Dame, Mieke A Mommaas, Henk K Koerten, Claire Wyman, Astrid AAM Danen‐van Oorschot, Jennifer L Rohn, Mathieu HM Noteborn, Jan Pieter Abrahams, Apoptin protein multimers form distinct higher-order nucleoprotein complexes with DNA Nucleic Acids Research. ,vol. 31, pp. 4805- 4813 ,(2003) , 10.1093/NAR/GKG661
Buyun Ma, Yanchun Wang, Xiumei Zhou, Panpan Huang, Rong Zhang, Tao Liu, Caixia Cui, Xinyuan Liu, Yigang Wang, Synergistic suppression effect on tumor growth of hepatocellular carcinoma by combining oncolytic adenovirus carrying XAF1 with cisplatin. Journal of Cancer Research and Clinical Oncology. ,vol. 141, pp. 419- 429 ,(2015) , 10.1007/S00432-014-1835-8
Li Xiao, Liu Yan, Wen Zhongmei, Li Chang, Lu Huijun, Tian Mingyao, Jin Kuoshi, Sun Lili, Gao Pegn, Yang Encheng, Xu Xiaohong, Kan Shifu, Wang Zhuoyue, Wang Yuhang, Jin Ningyi, Potent anti-tumor effects of a dual specific oncolytic adenovirus expressing apoptin in vitro and in vivo. Molecular Cancer. ,vol. 9, pp. 10- 10 ,(2010) , 10.1186/1476-4598-9-10